MEKTOVI vs OPDIVO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. MEKTOVI and OPDIVO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MEKTOVI	OPDIVO
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BINIMETINIB	NIVOLUMAB
Manufacturer	Array Biopharma Inc	Bristol Myers Squibb
Dosage forms	Tablet	Injectable
Drug class	—	Programmed Death Receptor-1 Blocking Antibody
Boxed warning	None	None
Treats	Melanoma	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma

mektovi opdivo

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

BINIMETINIB

NIVOLUMAB

Manufacturer

Array Biopharma Inc

Bristol Myers Squibb

Dosage forms

Tablet

Injectable

Drug class

—

Programmed Death Receptor-1 Blocking Antibody

Boxed warning

None

Treats

Melanoma

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma

Frequently asked questions

What is the difference between Mektovi and Opdivo?

Mektovi contains Binimetinib, while Opdivo contains Nivolumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.